Wells' syndrome associated with chronic myeloid leukaemia

Acta Derm Venereol. 2013 May;93(3):375-6. doi: 10.2340/00015555-1483.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Biopsy
  • Cellulitis / complications*
  • Cellulitis / pathology
  • Eosinophilia / complications*
  • Eosinophilia / pathology
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Male
  • Middle Aged
  • Protein Kinase Inhibitors / administration & dosage
  • Pyrimidines / administration & dosage
  • Skin / drug effects
  • Skin / pathology*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Fusion Proteins, bcr-abl
  • nilotinib

Supplementary concepts

  • Wells syndrome